The present study provides evidence that TREM2 is required for preventing loss of memory and learning in Alzheimer’s disease by regulating C/EBPα-dependent CD36 expression and the consequent Aβ phagocytosis. The gene discussed is CEBPA; the disease is early-onset autosomal dominant Alzheimer disease.